Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 1 of 1 for “"Cancer Immunotherapy; immune checkpoint; PARP inhibitor; Combination therapy"”.

  1. Parp Inhibitor Upregulates Pd-L1 Expression and Enhances Cancer-Associated Immunosuppression

    … antibodies that block CTLA4, PD-1 and PD-L1, immune checkpoints have emerged as new targets in cancer therapy. In addition, there is accumulating evidence highlighting the role of cancer-associated immunity in patient response to cytotoxic anticancer agents. Inhibitors of poly (ADP-ribose) …

    uthsc Repository record for Parp Inhibitor Upregulates Pd-L1 Expression and Enhances Cancer-Associated Immunosuppression (opens in a new tab)